Case report - sulfonylurea poisoning mimicking vertebrobasilar acute ischemic stroke

Background: We report the case of sulfonylurea induced hypoglycemia manifesting as acute encephalopathy with focal neurological signs misdiagnosed as posterior circulation acute ischemic stroke (AIS) and discuss the potential effects of hypoglycemia on central nervous system, as well as its differe...

Full description

Bibliographic Details
Published in:	Journal of Education, Health and Sport
Main Authors:	Kamila Kędra, Izabela Michalik, Michał Oleszko, Marcin Wiącek
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2023-04-01
Subjects:	sulfonylurea-poisoning neuroglycopenia tetraplegia hemiparesis
Online Access:	https://apcz.umk.pl/JEHS/article/view/43189

Similar Items

Comparison of decision tree with common machine learning models for prediction of biguanide and sulfonylurea poisoning in the United States: an analysis of the National Poison Data System
by: Omid Mehrpour, et al.
Published: (2023-04-01)

Infantile Neuroglycopenia
by: J Gordon Millichap
Published: (2007-05-01)

Application of the screening test principles to screening for neonatal hypoglycemia
by: J. M. Alsweiler, et al.
Published: (2022-12-01)

Neuroglycopaenia presenting as isolated aphasia
by: Zhemin Wang, et al.
Published: (2021-09-01)

Photodegradation of Flucetosulfuron, a Sulfonylurea-Based Herbicide in the Aqueous Media Is Influenced by Ultraviolet Irradiation
by: Arnab Goon, et al.
Published: (2021-11-01)

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
by: Kunavisarut T, et al.
Published: (2019-05-01)

Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study
by: Mohammad Rezazadeh, et al.
Published: (2024-10-01)

Design, synthesis and in vitro evaluation of novel sulfonylurea and sulfonylthiourea as ectonucleotidases inhibitors
by: Abdullah Yahya Abdullah Alzahrani, et al.
Published: (2024-01-01)

Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real‐world data from pharmacies in Japan
by: Michiko Yamazaki, et al.
Published: (2024-11-01)

Ischemic Stroke in Childhood
by: J Gordon Millichap
Published: (1989-04-01)

Using Pharmacoepidemiology to Examine the Interplay of Sulfonylureas and Infection Risk in Patients With Diabetes Mellitus
by: Yu‐ying Wu, et al.
Published: (2025-04-01)

Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
by: Lyudmila Viktorovna Nedosugova
Published: (2013-06-01)

A Five‐Year Journey to Diagnosis: Resolving Persistent Hypoglycemia Through Successful Insulinoma Resection—A Case Report
by: Ankit Shrestha, et al.
Published: (2025-03-01)

An Overlapping Presentation of Hypoglycemia and Catatonia—A Case Report and Literature Review
by: Einat Mader, et al.
Published: (2022-11-01)

Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
by: Alla Vsevolodovna Rudakova
Published: (2011-09-01)

The impact of sulfonylureas on diverse ion channels: an alternative explanation for the antidiabetic actions
by: Xian-Tao Li, et al.
Published: (2025-06-01)

OCTREOTIDE FOR TREATMENT RECURRENT HYPOGLYCEMIA INDUCED BY SULFONYLUREA: A CASE REPORT AND LITERATURE REVIEW
by: Yuddy Imowanto, et al.
Published: (2024-09-01)

Complementary Strategy Enhancing Broad-Specificity for Multiplexed Immunoassay of Adulterant Sulfonylureas in Functional Food
by: Zhaodong Li, et al.
Published: (2022-08-01)

Sulfonylureas or biguanides is associated with a lower risk of rheumatoid arthritis in patients with diabetes: A nationwide cohort study
by: Yu-Jih Su, et al.
Published: (2022-07-01)

Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study
by: Khaled Naja, et al.
Published: (2024-09-01)

Transformation of Iodosulfuron-Methyl into Ionic Liquids Enables Elimination of Additional Surfactants in Commercial Formulations of Sulfonylureas
by: Witold Stachowiak, et al.
Published: (2021-07-01)

Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation
by: Bodo Haas, et al.
Published: (2024-07-01)

Giant left atrial myxoma causing acute ischemic stroke in a child
by: Hayato Ise, et al.
Published: (2018-01-01)

Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes
by: Pamela Bowman, et al.
Published: (2023-12-01)

Clinical features and sulfonylurea usage among outpatients with diabetes aged ≥90 years in an urban diabetes clinic in Tokyo
by: Toshiko Kobori, et al.
Published: (2022-12-01)

aThe characteristics of glucose metabolism in the sulfonylurea receptor 1 knockout rat model
by: Xiaojun Zhou, et al.
Published: (2019-01-01)

Feasibility of efficacious therapy of diabetes mellitus by sulfonylurea agents in neonates with KCNJII gene mutation: originalobservation
by: Andrey Olegovich Emel'yanov, et al.
Published: (2009-09-01)

Simultaneous determination of sulfonylurea herbicides in tomatoes using the QuEChERS method coupled with HPLC
by: Sang Gyu Han, et al.
Published: (2024-02-01)

Live Cell Monitoring of Phosphodiesterase Inhibition by Sulfonylurea Drugs
by: Filip Berisha, et al.
Published: (2024-08-01)

The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review
by: Aleksey Vadimovich Zilov, et al.
Published: (2010-06-01)

Reversible focal splenial lesion on diffusion-weighted MRI in sulfonylurea intoxication
by: K Aslan, et al.
Published: (2015-09-01)

A Case Report of Acute Ischemic Stroke Following Scorpion Sting: That’s Too Coincidental To Be Coincidence
by: Taufiq Abdullah, et al.
Published: (2025-04-01)

Chronic Microvascular Complications in Sulfonylureas-Treated Diabetic Patients: Correlations with Glycemic Control, Risk Factors and Duration of the Disease
by: Luminita-Georgeta Confederat, et al.
Published: (2024-12-01)

Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
by: Vallo Volke, et al.
Published: (2022-10-01)

Evaluation of the efficiency and safety of therapy with a combination of sulfonylurea derivatives and insulin sensitizers for type 2 diabetes mellitus
by: O N Goncharenko, et al.
Published: (2012-08-01)

Novel Sulfonylurea Derivatives as Potential Antimicrobial Agents: Chemical Synthesis, Biological Evaluation, and Computational Study
by: Fan-Fei Meng, et al.
Published: (2023-02-01)

Assessing the environmental risks of sulfonylurea pollutants: Insights into the risk priority and structure-toxicity relationships
by: Zhi-Cong He, et al.
Published: (2025-03-01)

Weed Pressure, Nutrient Content, and Seed Yield in Field Grown Sulfonylurea-Resistant <i>Camelina sativa</i> and <i>Brassica napus</i>
by: James V. Anderson, et al.
Published: (2022-10-01)

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
by: Hassoun AAK, et al.
Published: (2016-07-01)

Augmented muscle activation in reaching movements after stroke
by: Paula Vieira, et al.
Published: (2020-01-01)